A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets

NCT07124221 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperprolactinemia

Interventions

DRUG: Cabergoline tablets
DRUG: Bromocriptine mesylate tablets

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.